Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicenter phase 4 study of Baqsimi for level 2 or level 3 hypoglycemia in insulin-treated patients with diabetes
CTR20262452Phase 4Active
- Sponsor
- Amphastar Pharmaceuticals
- Start
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of glucagon in hypoglycaemia, sponsored by Amphastar Pharmaceuticals. Started Jul 2026; status: active.
02
Drugs
glucagon
03
Conditions
hypoglycaemia
Beyond the preview
Go deeper on CTR20262452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262452.